Hamlet BioPharma is a pharmaceutical company with strong links to research.
Hamlet BioPharma has raised $967K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Hamlet BioPharma's investors include European Commission.
Hamlet BioPharma is headquartered in Lund, Sweden.
Hamlet BioPharma is a pharmaceutical company with strong links to research.
Hamlet BioPharma is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hamlet BioPharma — Funding & Investors." VCBacked, March 24, 2026, https://www.vcbacked.co/company/hamlet-biopharma. Accessed August 14, 2026.
VCBacked. (2026). Hamlet BioPharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/hamlet-biopharma
{{cite web |title=Hamlet BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/hamlet-biopharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated